Cell Expansion Market Size
Study Period | 2019 - 2029 |
Base Year For Estimation | 2023 |
CAGR | 15.10 % |
Fastest Growing Market | Asia Pacific |
Largest Market | North America |
Market Concentration | Medium |
Major Players*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Cell Expansion Market Analysis
The cell expansion market will show rapid growth due to the increasing incidence of chronic diseases, government investments for cell-based research and increasing focus on R&D for cell-based therapies.
The rising prevalence of chronic diseases coupled with increasing research activities for cell-based research is found to be the major factor driving the cell expansion market. Cardiovascular disease (CVD) is the leading cause of mortality worldwide. According to the WHO, an estimated 17.9 million people died from CVDs in 2016, representing 31% of all global deaths.
There is an increase in the prevalence of cancer patients that results in a large patient pool, which creates an opportunity for the manufacturers to tap and capitalize on the market. Hence there is an increase in the cases of chronic diseases that are expected to drive the overall market. Furthermore, technological advances in cell expansion devices and growth in government investments regarding healthcare issues are the factors propelling the market.
Cell Expansion Market Trends
This section covers the major market trends shaping the Cell Expansion Market according to our research experts:
Consumables is Expected to be the Largest Growing Segment in the Cell Expansion Market
The consumables segment has been accounted for the largest share of the market and this is mainly due to the high demand during the production of regenerative medicine and rising research activities on stem cells in the biopharmaceutical companies. There is also a constant requirement for new reagents among end-users that helps in market growth. Furthermore, the rising awareness regarding advanced treatment therapies such as personalized medicine is also another driving factor for this segment.
North America is Found Leading the Cell Expansion Market
The increasing incidences of chronic and cell-based diseases and rising geriatric population are the key factors driving the overall market in this region. The rising investment made by the companies as well as the government for cell expansion research is also a factor driving the market in this region.
The Asia Pacific is poised to grow owing to rapidly expanding biotechnology and biopharmaceutical industries, increasing government investments for cancer and stem cell research and rising focus of prominent players on the emerging markets.
Cell Expansion Industry Overview
There has been a presence of a considerable number of companies that are mainly focusing on agreements and expansions to strengthen its business operations. There are various established business players that are adopting numerous organic and inorganic growth strategies to increase their market share. New product launches, mergers and acquisitions, partnerships, and collaborations are the key strategies undertaken by these companies for sustainable growth.
Cell Expansion Market Leaders
Thermo Fisher Scientific, Inc.
Becton, Dickinson and Company
Terumo BCT
Merck KGaA
GE Healthcare
*Disclaimer: Major Players sorted in no particular order
Cell Expansion Market Report - Table of Contents
-
1. INTRODUCTION
-
1.1 Study Deliverables
-
1.2 Study Assumptions
-
1.3 Scope of the Study
-
-
2. RESEARCH METHODOLOGY
-
3. EXECUTIVE SUMMARY
-
4. MARKET DYNAMICS
-
4.1 Market Overview
-
4.2 Market Drivers
-
4.2.1 Increasing Incidence of Chronic Diseases
-
4.2.2 Government Investments for Cell-Based Research
-
4.2.3 Increasing Focus on R&D for Cell-Based Therapies
-
-
4.3 Market Restraints
-
4.3.1 Ethical Concerns Regarding Research in Cell Biology
-
-
4.4 Porter's Five Force Analysis
-
4.4.1 Threat of New Entrants
-
4.4.2 Bargaining Power of Buyers/Consumers
-
4.4.3 Bargaining Power of Suppliers
-
4.4.4 Threat of Substitute Products
-
4.4.5 Intensity of Competitive Rivalry
-
-
-
5. MARKET SEGMENTATION
-
5.1 By Product
-
5.1.1 Consumables
-
5.1.2 Reagents, Media, & Serum
-
5.1.3 Disposables
-
5.1.4 Instruments
-
5.1.4.1 Cell Expansion Supporting Equipment
-
5.1.4.2 Bioreactors
-
5.1.4.3 Automated Cell Expansion Systems
-
-
-
5.2 By Cell Type
-
5.2.1 Human Cells
-
5.2.2 Animal Cells
-
-
5.3 By Application
-
5.3.1 Regenerative Medicine and Stem Cell Research
-
5.3.2 Cancer and Cell-Based Research
-
5.3.3 Other Applications
-
-
5.4 By End User
-
5.4.1 Biotechnology & Biopharmaceutical Companies
-
5.4.2 Research Institutes
-
5.4.3 Others
-
-
5.5 Geography
-
5.5.1 North America
-
5.5.1.1 United States
-
5.5.1.2 Canada
-
5.5.1.3 Mexico
-
-
5.5.2 Europe
-
5.5.2.1 Germany
-
5.5.2.2 United Kingdom
-
5.5.2.3 France
-
5.5.2.4 Italy
-
5.5.2.5 Spain
-
5.5.2.6 Rest of Europe
-
-
5.5.3 Asia-Pacific
-
5.5.3.1 China
-
5.5.3.2 Japan
-
5.5.3.3 India
-
5.5.3.4 Australia
-
5.5.3.5 South Korea
-
5.5.3.6 Rest of Asia-Pacific
-
-
5.5.4 Middle-East and Africa
-
5.5.4.1 GCC
-
5.5.4.2 South Africa
-
5.5.4.3 Rest of Middle East and Africa
-
-
5.5.5 South America
-
5.5.5.1 Brazil
-
5.5.5.2 Argentina
-
5.5.5.3 Rest of South America
-
-
-
-
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
-
6.1.1 Thermo Fisher Scientific, Inc.
-
6.1.2 Becton, Dickinson and Company
-
6.1.3 Terumo BCT
-
6.1.4 Merck KGaA
-
6.1.5 Beckman Coulter Inc. (Subsidiary of Danaher Corporation)
-
6.1.6 Miltenyi Biotec
-
6.1.7 Lonza Group LTD.
-
6.1.8 Stemcell Technologies, Inc.
-
6.1.9 GE Healthcare
-
6.1.10 Takara Bio Inc.
-
- *List Not Exhaustive
-
-
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Cell Expansion Industry Segmentation
As per the scope of the report, cell expansion deals with the production of daughter cells that arise from a single cell. This process is used in therapeutic development, drug screening, and microlevel research of cells. Presently, cell expansion is widely used to improve transplantation and in the treatment of various diseases such as rheumatoid arthritis, diabetes, and others. Cell expansion also ensures to simplify the overall task and to reduce labor-intensive manual tasks that are associated with the process.
By Product | |||||
Consumables | |||||
Reagents, Media, & Serum | |||||
Disposables | |||||
|
By Cell Type | |
Human Cells | |
Animal Cells |
By Application | |
Regenerative Medicine and Stem Cell Research | |
Cancer and Cell-Based Research | |
Other Applications |
By End User | |
Biotechnology & Biopharmaceutical Companies | |
Research Institutes | |
Others |
Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Cell Expansion Market Research FAQs
What is the current Cell Expansion Market size?
The Cell Expansion Market is projected to register a CAGR of 15.10% during the forecast period (2024-2029)
Who are the key players in Cell Expansion Market?
Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, Terumo BCT, Merck KGaA and GE Healthcare are the major companies operating in the Cell Expansion Market.
Which is the fastest growing region in Cell Expansion Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Cell Expansion Market?
In 2024, the North America accounts for the largest market share in Cell Expansion Market.
What years does this Cell Expansion Market cover?
The report covers the Cell Expansion Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Cell Expansion Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Cell Expansion Industry Report
Statistics for the 2024 Cell Expansion market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Cell Expansion analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.